Literature DB >> 2865616

Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukaemia.

S Vitols, G Gahrton, M Björkholm, C Peterson.   

Abstract

59 patients with acute leukaemia were examined to see if hypocholesterolaemia, which is commonly found in acute leukaemia, was due to the high low-density-lipoprotein (LDL)-receptor activity of leukaemic cells. LDL-receptor activity was found to be inversely correlated with plasma-cholesterol concentration. Patients with both a high LDL-receptor activity per cell and a high white-blood-cell count had the lowest cholesterol concentrations. During chemotherapy, cholesterol levels rose concomitantly with the disappearance from the peripheral blood of leukaemic cells. Hypocholesterolaemia in leukaemia and other neoplastic disorders may be due to increased LDL-receptor activity in the malignant cells. This high uptake and degradation of LDL by malignant cells could be utilised to target neoplastic cells with LDL-bound chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865616     DOI: 10.1016/s0140-6736(85)92679-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  52 in total

1.  Lipoprotein distribution of a novel endotoxin antagonist, E5531, in plasma from human subjects with various lipid levels.

Authors:  K M Wasan; F W Strobel; S C Parrott; M Lynn; W J Christ; L D Hawkins; D P Rossignol
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Serum cholesterol in cerebral malignancies.

Authors:  P Grieb; M S Ryba; J Jagielski; W Gackowski; P Paczkowski; S J Chrapusta
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

3.  Quantitative Proteomics Reveals the Roles of Peroxisome-associated Proteins in Antiviral Innate Immune Responses.

Authors:  Mao-Tian Zhou; Yue Qin; Mi Li; Chen Chen; Xi Chen; Hong-Bing Shu; Lin Guo
Journal:  Mol Cell Proteomics       Date:  2015-06-29       Impact factor: 5.911

4.  Statins reduce the risk of cancer-related mortality in cancer-diagnosed patients. A true phenomenon?

Authors:  Stella Trompet; Anton Jm de Craen; J Wouter Jukema
Journal:  Ann Transl Med       Date:  2013-04

5.  Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer.

Authors:  V Michalaki; G Koutroulis; K Syrigos; C Piperi; A Kalofoutis
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

6.  Characteristics of association of oleoyl derivatives of 5-fluorodeoxyuridine and methotrexate with low-density lipoproteins (LDL).

Authors:  P C de Smidt; T J van Berkel
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

7.  Effect of intralipid infusion on serum high- and low-density lipoprotein cholesterol, lecithin:cholesterol acyltransferase, and lipoprotein lipase in tumor-bearing rats.

Authors:  K M Wasan; V B Grossie
Journal:  Experientia       Date:  1995-03-15

8.  Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation.

Authors:  M Rudling; M Gåfvels; P Parini; G Gahrton; B Angelin
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

9.  Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies.

Authors:  K M Wasan; A L Kennedy; S M Cassidy; M Ramaswamy; L Holtorf; J W Chou; P H Pritchard
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Association of the endotoxin antagonist E5564 with high-density lipoproteins in vitro: dependence on low-density and triglyceride-rich lipoprotein concentrations.

Authors:  Kishor M Wasan; Olena Sivak; Richard A Cote; Aaron I MacInnes; Kathy D Boulanger; Melvyn Lynn; William J Christ; Lynn D Hawkins; Daniel P Rossignol
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.